Heavy metals are known as serious toxicants and carcinogens, and environmental pollution from industrial and agricultural waste increase the risk of their exposure to human and animals [35, 36]. Cd toxicity has shown to be associated with apoptosis, oxidative stress, and DNA damage through various mechanism [37]. In this study, we investigated the role of liposomal silymarin against Cd toxicity in MRC-5 human fibroblast lung cells as well as A 549 adenocarcinomic human alveolar basal epithelial cells. Our observation indicated that liposomal form of silymarin could significantly reduce Cd toxic effects on both cells and improve cell recovery following Cd exposure.
As previously reported, inhalation is the main route of Cd exposure and many lung diseases are attributed to the inflammation caused by Cd. The Cd retention in the lungs and other organs results in an impaired function of the host immunity and susceptibility to bacterial colonization and the subsequent chronic inflammation [38]. Experimental investigation at cellular levels indicated that the up-regulation of several cytokines including IL-6 and MIP-2/CXCL2 in the human M1 fibroblasts and MIP-2, IL-1β and TNF-α in alveolar macrophages may have implications in the development of Cd-induced lung damage [39]. Also, Cd at certain concentrations (20 to 60 µM) could increase the intracellular ROS levels in BEAS-2B human bronchial epithelial cells, resulting in the activation of apoptosis related pathways including JNK, ERK and p38 MAPK [40].
We compared the toxicity of Cd in both normal and cancer cells. Our results indicated that a significantly lower concentration of Cd could induce toxic effects in cancer cells compared to the normal cells. Further, we have shown that Cd exposure could significantly increase ROS generation and sub-G1 population in both cells. Results also indicated that Cd could increase the cleaved caspase 3 expression to a significant level in MRC-5 cells compared to A 549. Cd effect on ROS generation in C6 glioma cells has shown to be attributed to a Fenton-type reaction resulting in oxidative stress induction [41]. Oh et all. have shown that ROS generation following Cd treatment could trigger apoptosis through caspase-dependent pathway including caspases 3, 8 and 9 in HepG2 cells [42].
Numerous studies indicated the protective roles of essential metals, vitamins, edible plants, phytochemicals, probiotics and other dietary supplements against Cd toxicity [43]. Several reports also revealed direct competition of Zn with Cd for uptake through Zn transporters, calcium channels, and DMT1 (divalent metal transporter 1), however there are also other mechanisms including metallothionein induction and redox homeostasis [44]. The role of oxidative stress following chronic Cd toxicity has long been demonstrated and it was shown that co-treatment with antioxidative agents could be promising [45]. Chelating agents and their combination with antioxidants including ascorbic acid, alpha-tocopherol, and selenium have shown to protect against Cd toxicity in experimental animals [46–49].
In recent years, numerous studies have demonstrated the use of medicinal herbs as a potential treatment for detoxification of heavy metals due to the clearly fewer adverse reactions compared to chemical chelators [50]. Silymarin (SL), a polyphenolic flavonoid known for its promising pharmacological activities has received tremendous attention over the last decades. The antioxidant features of SL play a central role in its protective actions including direct scavenging of free radicals and chelating free elements, maintaining cellular redox balance, inhibiting ROS-producing enzymes, improving the integrity of mitochondria in stress conditions and decreasing inflammation responses [51]. Various experimental models have also shown the antioxidant effect of free SL against drugs adverse reactions as well as toxicants including arsenic [52, 53] and manganes [18, 54, 55]. It’s been shown that the protective effects attributed to silymarin might arise from its ability to trap free radicals and its chelating property including ferrous ions chelating activities [56].
The absence of ionizable groups and low aqueous solubility however, negatively affect silymarin bioavailability and its penetration through the biological barriers. These shortcomings could be modulated using nanotechnology-based drug delivery systems by improving SL solubility and penetration properties. In the past two decades, there have been exciting progress in the field of nanomedicine, outlining nanoparticle capabilities for effective cellular interaction and subcellular targeting. Among various promising drug delivery systems, liposomes represent an advanced technology that paved the way to the clinic. The key feature of liposome is addressing two main issues in drug therapy including improving the stability and physicochemical properties of the entrapped agent as well as targeting the inflammatory tissues [57].
Our data indicated that higher concentrations of silymarin liposome (above 25 µM) exerted a considerable toxicity in both cells, while lower concentrations (10 and 2.5 µM for MRC-5 and A 549 cancer cells, respectively) exhibited a protective and anti-oxidant role in both cells. Indeed, SL-L at certain concentrations was effective in improving cell viability following Cd exposure in both A549 and MRC-5 cells, with comparable results to that of NAC as a well-known antioxidant [32]. These results clearly clarify a concentration-dependent pro-oxidant and anti-oxidant feature attributed to the liposomal form of silymarin. Further, SL-L at lower concentrations was capable of improving the viability of A549 cell compared to MRC-5 cells. We also examined the protective effects of SL-L on the apoptosis induction and we have observed the same trend. Treatment with SL-L increased the sub-G1 population of both cells exposed to Cd, however, lower concentrations of SL-L was required to reduce the aforementioned cell population in A 549 cells (2.5 µM) compared to MRC-5 cells (5 µM).
The intrinsic apoptotic pathway of cell death is directed by caspases-9 and − 3 and is activated by different types of cell stress. There are reports indicating that caspase-3 inhibition could protect against the oxidative stress induced by Cd, thus suggesting caspase-3 activation as a major contributor to the generation of reactive oxygen species (ROS) [58]. Our study demonstrated that SL-L treatment could reduce the cleaved caspase 3 protein expression in both cells. We have also shown that significantly lower concentrations of SL-L is required to exert the same effects in A 549 cancer cells compared to MRC-5 cells. There are however conflicting results in the literature, for example, Shih et al. have failed to show the activation of pro-caspase-3 and cleavage of PARP following Cd exposure and concluded that Cd mechanism of toxicity is attributed to the mitochondria-mediated AIF translocation into the nucleus [59]. The PARP protein is also an important downstream molecule in the apoptotic pathway and is thought to be a marker of caspase-3 protein activation of cells undergoing apoptosis [60]. Our data demonstrated that treatment with SL-L could obviously decrease the PARP cleavage and the subsequent inactivation following Cd exposure in both cells.
The protective role of free SL against Cd toxicity was previously reported in several experimental animal models. For example, silymarin and milk thistle have shown to reduce the toxic effects of Cd in male Japanese quail [61]. Additionally, SL reversed Cd toxicity by inhibiting lipid peroxidation and improving the total antioxidant power in adult mice [62]. Herein, we report for the first time that the liposomal form of silymarin could exert both pro- and anti-oxidant effects on the cells and that the concentration- dependent antioxidant properties could protect both normal and cancerous cells against Cd toxicity. However, obviously lower concentrations are effective in protecting A 549 cancer cells compared to MRC-5 normal cells.
Though there are no clear evidence on the concentration-dependent effects of polyphenolic compounds in normal versus cancer cells, it is likely that due to some unknown mechanisms the polyphenolic compounds exerts their antioxidants effects at lower concentrations in cancer cells. Another possibility might be the enhanced uptake by the actively proliferating cancer cells to meet their higher demands of nutrient requirement. Indeed, the nutrient uptake in normal cells is a well-organized process, which accelerates in abnormally high proliferative cancer cells [63]. Previously, a study of pancreatic tumor xenograft model revealed a strikingly increased albumin uptake by the cancer cells to meet their high glutamine demand [64]. There are also insights into the effect of polyphenols as a potent antioxidant, by scavenging ROS, chelating transition metals or upregulating antioxidant enzymes, or a prominent pro-oxidant through forming free radicals [65]. For instance, though the anti-aging effects of resveratrol in age-related human diseases have been revealed, it’s been shown that depends on the exposed concentrations and the type of the cells, resveratrol could exhibit pro-oxidant properties leading to oxidative DNA damage [66]. Another example is evidence implicating the potential of green tea polyphenols in inducing ROS-mediated cancer cell death. Nevertheless, depending on the concentration of polyphenols and physiologic context of the interaction, it has been shown that polyphenolic compounds could scavenge ROS under conditions of high oxidative stress, thus preventing cell damage [48, 67–69].